Condition
Drug Refractory Epilepsy
Total Trials
4
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Recruiting2
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07012148Not ApplicableRecruiting
Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables
NCT06292494Not ApplicableRecruiting
Focused Ultrasound for Drug-resistant Epilepsy
NCT05042726Not ApplicableCompletedPrimary
cTBS Targeting Cerebellum for Drug-refractory Epilepsy
NCT03860298Not ApplicableCompleted
Safety of Using NaviFUS System in Patients With Drug Resistant Epilepsy
Showing all 4 trials